Your browser doesn't support javascript.
loading
A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME.
Xiao, Xuejun; Peng, Yan; Wang, Zheyue; Zhang, Louqian; Yang, Tingting; Sun, Yangyang; Chen, Yufeng; Zhang, Wenqing; Chang, Xinxia; Huang, Wen; Tian, Shuning; Feng, Zhenqing; Xinhua, Nabi; Tang, Qi; Mao, Yuan.
Afiliação
  • Xiao X; Department of Pharmacology, Xinjiang Medical University, Urumqi, China.
  • Peng Y; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
  • Wang Z; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
  • Zhang L; Department of Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Yang T; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
  • Sun Y; Department of Pathology, Changzhou No. 2 People's Hospital Affiliated with Nanjing Medical University, Changzhou, China.
  • Chen Y; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
  • Zhang W; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
  • Chang X; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
  • Huang W; Department of Oncology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Tian S; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China.
  • Feng Z; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
  • Xinhua N; Department of Pharmacology, Xinjiang Medical University, Urumqi, China. Electronic address: Xinhua_xmu@126.com.
  • Tang Q; NHC Key Laboratory of Antibody Technique, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Center of Antibody Drug, Nanjing Medical University, Nanjing, China; Department of Pathology, Changzhou No. 2 People's Hospital Affiliated with Nanjing Medical University, Chan
  • Mao Y; Department of Oncology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Oncology, Geriatric Hospital of Nanjing Medical University, Nanjing, China; Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China. Elect
Pharmacol Res ; 181: 106269, 2022 07.
Article em En | MEDLINE | ID: mdl-35605813

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macrófagos / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macrófagos / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article